KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $9,253,000 | +340.6% | 51,461 | +154.0% | 0.01% | +266.7% |
| Q2 2017 | $2,100,000 | +510.5% | 20,259 | +229.4% | 0.00% | +200.0% |
| Q3 2016 | $344,000 | +11.7% | 6,150 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $308,000 | -13.2% | 6,150 | -20.5% | 0.00% | 0.0% |
| Q1 2016 | $355,000 | -81.8% | 7,740 | -75.5% | 0.00% | -66.7% |
| Q4 2015 | $1,951,000 | -20.0% | 31,656 | -27.7% | 0.00% | -40.0% |
| Q3 2015 | $2,438,000 | +372.5% | 43,795 | +417.8% | 0.01% | +400.0% |
| Q2 2015 | $516,000 | – | 8,458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|